Myopia clinical trials at UCSF

1 research study open to eligible people

Myopia is a condition where faraway objects look blurry. UCSF is investigating the effects of red-light therapy on myopia control, using a new technology that involves low-level light exposure. This research is part of ongoing trials to find innovative methods for managing myopia.

Showing trials for

  • Repeated Low-level Red-light Therapy in Myopia Control

    open to eligible people ages 8-13

    Low-level red-light technology provides a new and innovative myopia control approach. This strategy enables relatively high energies of light to be delivered at much shorter durations of exposure to induce the myopia control effect. The efficacy of the low-level red-light technology has been proven in a Chinese population. This trial demonstrated that 3-minutes per session twice a day repeated low-level red-light treatment controlled 87.7% of refraction progression and 76.8% of axial length elongation when the time of compliance to the treatment was 75%. Repeating this RCT in culturally diverse groups will confirm and translate this technology into a solution for myopia control globally.

    San Francisco, California

Last updated: